AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial targets tough blood cancers and anemia
Disease control Recruiting nowThis early-phase study is testing a new cell therapy called GT801 in adults with advanced blood cancers or autoimmune anemia that has not responded to standard treatments. The main goals are to check if the treatment is safe and to see early signs of whether it helps control the …
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Massive study launches to map China's blood disease landscape
Knowledge-focused Recruiting nowThis study aims to gather detailed information on many different blood diseases in China, including cancers like leukemia and lymphoma, and conditions like hemophilia. It will follow 2,300 patients to learn how common these diseases are, what treatments patients receive, how well…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC